文献速递脊柱关节炎其他结缔组织病

亚临床银屑病关节炎:概念、困境与研究需求

Subclinical psoriatic arthritis: concepts, dilemmas, and research needs.
PubMed 文献 · Ann Rheum Dis · 2026-04-02

本文评述亚临床银屑病关节炎(PsA)的定义与争议,指出EULAR将无临床滑膜炎但有关节痛和/或影像异常定义为亚临床PsA,但缺乏验证的血清标志物、临床异质性和影像非特异性使风险分层困难,可能导致误分类和过度治疗。未来需纵向银屑病队列、先进分子影像和多组学标志物研究,并警惕过度扩展亚临床概念。

要点

  • EULAR将亚临床PsA定义为无临床滑膜炎但有关节痛和/或影像异常。
  • 缺乏验证的血清标志物和影像特异性使亚临床PsA风险分层困难。
  • 需纵向队列、分子影像和多组学标志物研究以支持靶向预防。

核心结论

  • 亚临床PsA概念有临床价值但定义未统一,需警惕过度诊断和过度治疗。

研究设计与样本

  • 本文为观点性综述,未报告系统检索方法或样本量。

主要发现

  • 高达三分之一的银屑病(PsC)患者会发展为PsA,亚临床阶段受到关注。
  • 缺乏验证的血清生物标志物、PsA临床异质性、非特异性肌肉骨骼症状和影像学低特异性使风险分层复杂化。
  • 类风湿关节炎的经验提示将预防范式用于亚临床疾病既有潜力也有陷阱。

关键数值与推荐

  • EULAR提出的实用定义:亚临床PsA为无临床滑膜炎情况下的关节痛和/或影像学异常。

临床怎么用

  • 临床应谨慎应用亚临床PsA概念,避免对非特异性症状和影像异常过度干预。
  • 未来需建立稳健风险分层模型以识别真正进展风险者并支持靶向预防。

局限性

  • 本文为观点性文章,未提供原始研究数据或验证性结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Psoriatic arthritis (PsA) develops in up to one-third of patients with psoriasis (PsC), yet increasing attention is now focused on a putative subclinical phase preceding overt arthritis. Several conceptual frameworks describe the PsC-PsA transition, including the pragmatic definition proposed by the European Alliance of Associations for Rheumatology, which defines subclinical PsA as arthralgia and/or imaging abnormalities in the absence of clinical synovitis. However, the absence of validated serological biomarkers, the marked clinical heterogeneity of PsA, the frequent occurrence of nonspecific musculoskeletal symptoms, and the limited specificity of imaging findings complicate risk stratification and may lead to misclassification and overtreatment. Lessons from rheumatoid arthritis highlight both the potential and the pitfalls of applying prevention paradigms to subclinical disease. This viewpoint critically appraises current definitions of subclinical PsA, discusses therapeutic and trial-design implications, and outlines key research priorities, including longitudinal PsC cohorts, advanced and molecular imaging, and multiomic biomarker discovery. Future progress depends on developing robust risk-stratification models that capture the full spectrum of psoriatic disease and enable targeted prevention strategies while minimising unnecessary intervention. At the same time, caution is warranted against broad expansion of the 'subclinical' disease state concept, as it may dilute disease definitions, increase overdiagnosis, and divert attention from improving early and accurate identification of clinically meaningful PsA.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Kharouf F, Mehta P, Carrizo Abarza V, et al. Subclinical psoriatic arthritis: concepts, dilemmas, and research needs. Ann Rheum Dis. 2026. PMID: 41934034. doi:10.1016/j.ard.2026.03.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。